Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma
The autoantigens of a new category of treatment‐responsive paraneoplastic encephalitis are reported, and it is proposed that this category should be combined with existing treatment-responsive encephalopathy categories.
Recommended diagnostic criteria for paraneoplastic neurological syndromes
An international panel of neurologists interested in PNS recommended new criteria for those in whom no clinical consensus was reached in the past and defined “classical” syndrome and onconeural antibody as “well characterised”.
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
- S. Gultekin, M. Rosenfeld, R. Voltz, J. Eichen, J. Posner, J. Dalmau
- Medicine, PsychologyBrain : a journal of neurology
- 1 July 2000
The combination of symptoms, MRI findings and paraneoplastic antibodies established the diagnosis of PLE in 78% of the patients, and treatment of the tumour appeared to have more effect on the neurological outcome than the use of immune modulation.
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents
To report the clinical features of anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in patients ≤ 18 years old.
Paraneoplastic syndromes of the CNS
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
These studies establish the cellular mechanisms through which antibodies of patients with anti-NMDAR encephalitis cause a specific, titer-dependent, and reversible loss of NMDARs.